Kyverna Therapeutics Inc (KYTX)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current KYTX market cap is 135.99M. The company's latest EPS is USD -1.3983 and P/E is -2.15.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -21.38M | -29.36M | -33.44M | -38.77M |
| Net Income | -20.67M | -26.69M | -28.8M | -34.49M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Revenue | 5.66M | 7.03M | 0 |
| Operating Income | -26.35M | -29.38M | -62.41M |
| Net Income | -26.35M | -28.89M | -60.37M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | ||
| Total Assets | 75.2M | 389.98M | 363.12M | 339.2M |
| Total Liabilities | 26.02M | 28.99M | 29.61M | 36.49M |
| Total Equity | -131.4M | 360.99M | 333.51M | 302.71M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Assets | 85.49M | 66.92M | 75.2M |
| Total Liabilities | 23.02M | 20.25M | 26.02M |
| Total Equity | -46.25M | -74M | -131.4M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | ||
| Operating | -52.41M | -25.53M | -49.7M | -77.19M |
| Investing | -8.79M | -122.88M | -190.8M | -190.12M |
| Financing | 58.12M | 338.05M | 337.48M | 337.33M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Operating | -22.16M | -36.11M | -52.41M |
| Investing | -1.29M | -14.1M | -8.79M |
| Financing | 72.52M | 11.88M | 58.12M |
| Market Cap | 135.99M |
| Price to Earnings Ratio | -2.15 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.74 |
| Price to Book Ratio | 2.63 |
| Dividend Yield | - |
| Shares Outstanding | 43.17M |
| Average Volume (1 week) | 361.78k |
| Average Volume (1 Month) | 457.32k |
| 52 Week Change | -90.80% |
| 52 Week High | 35.01 |
| 52 Week Low | 3.00 |
| Spread (Intraday) | 0.2 (6.25%) |
| Company Name | Kyverna Therapeutics Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://kyvernatx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
